InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
1
T+90 hit rate
58%
T+90 mean return
+3.3%
Across 19 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by MILANO VINCENT, Director. Insider active across 3 companies, notably Biocryst Pharmaceuticals INC. Aggregated, 25 filings have been recorded. Split: 3 buys · 1 sell. Total volume traded: €251k. History available since 24 November 2021. The latest transaction was disclosed on 29 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations25 total
15,294 sharesCommon StockSEC:0000882796-26-000041:0
11,580 sharesCommon StockSEC:0001187159-26-000002:0
1,122 shares@ US$8.910.0005% mcap2.7% of flowCommon StockSEC:0000882796-26-000027:0
783 shares@ US$7.181.5% of flowCommon StockSEC:0000882796-25-000019:0
653 shares@ US$8.611.7% of flowCommon StockSEC:0001127602-25-007884:0
750 shares@ US$7.501.7% of flowCommon StockSEC:0001127602-24-028290:0
647 shares@ US$8.691.6% of flowCommon StockSEC:0001127602-24-023304:0
6,820 shares0Common StockSEC:0001127602-24-018733:0
4,660 sharesCommon StockSEC:0001415889-24-015365:0
870 shares@ US$6.461.6% of flowCommon StockSEC:0001127602-24-017295:0
15,000 shares@ US$6.2526.9% of flowCommon StockSEC:0001127602-24-016188:0
Ideal exit: 14 Feb 2025 (T+270)
999 shares@ US$5.631.6% of flowCommon StockSEC:0001127602-24-008156:0
956 shares@ US$5.881.6% of flowCommon StockSEC:0001127602-23-028609:0
791 shares@ US$7.111.6% of flowCommon StockSEC:0001127602-23-023695:0
3,283 shares@ US$0.5331100.0% of flowCommon StockSEC:0001415889-23-012142:0
16,745 shares0Common StockSEC:0001127602-23-018779:0
4,507 sharesCommon StockSEC:0001209191-23-034465:0
680 shares@ US$8.271.6% of flowCommon StockSEC:0001127602-23-017562:0
635 shares@ US$8.851.7% of flowCommon StockSEC:0001127602-23-008400:0
421 shares@ US$13.361.7% of flowCommon StockSEC:0001127602-22-026828:0
404 shares@ US$13.901.7% of flowCommon StockSEC:0001127602-22-022018:0
12,866 shares0Common StockSEC:0001127602-22-017167:0
3,356 sharesCommon StockSEC:0001209191-22-034592:0
7,500 shares@ US$12.1925.4% of flowCommon StockSEC:0001171843-21-008177
Ideal exit: 21 Aug 2022 (T+270)
7,500 shares@ US$12.190.0049% mcap50.0% of flowCommon StockSEC:0001171843-21-008177:0
Ideal exit: 21 Aug 2022 (T+270)
25 of 25 declarations
About MILANO VINCENT
Vincent Milano is a Director at BioCryst Pharmaceuticals Inc and Aclaris Therapeutics, Inc. As a board member, he participates in overseeing the activities of both companies. BioCryst Pharmaceuticals Inc. and Aclaris Therapeutics, Inc. are biopharmaceutical companies. Milano plays a key role in evaluating performance and strategic direction for both companies.
